Assessment of CTLA-4 Deficiency-Related Autoimmune Choroidopathy Response to Abatacept.
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Carol L
CL
Shields
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Emil A T
EA
Say
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Arman
A
Mashayekhi
Uveitis Unit of the Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Sunir J
SJ
Garg
Uveitis Unit of the Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
James P
JP
Dunn
Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Jerry A
JA
Shields
D000069594:Abatacept / Q000627:therapeutic use*; D000328:Adult; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000209:etiology; D060908:CTLA-4 Antigen / Q000172:deficiency*; D015862:Choroid Diseases / Q000188:drug therapy* / Q000209:etiology; D017074:Common Variable Immunodeficiency / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009887:Ophthalmoscopy; D041623:Tomography, Optical Coherence
D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D007166:Immunosuppressive Agents; D000069594:Abatacept